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ABSTRACT 
Loss of cognition is one of the age related mental problems and a characteristic symptom of neurodegenerative 
disorders like Alzheimer’s. Crataeva nurvala Buch-Ham, a well explored traditional Indian medicinal plant of 
Westernghats, is routinely used as folkloric medicine to treat various ailments in particular urolithiasis and neu-
rological disorders associated with cognitive dysfunction. The objective of the study was to evaluate the 
nootropic activity of Crataeva nurvala Buch-Ham stem bark in different learning and memory paradigm viz. El-
evated plus maze and Y-maze against scopolamine induced cognitive impairment. Moreover, to elucidate possi-
ble mechanism, we studied the influence of Crataeva nurvala ethanolic extract on central cholinergic activity via 
estimating the whole brain acetyl cholinesterase enzyme. Ethanolic extracts of Crataeva nurvala (100, 200 and 
400 mg/kg body weight) were administered to adult Wistar rats for successive seven days and the acquisition, re-
tention and retrieval of spatial recognition memory was determined against scopolamine (1 mg/kg, i.p.) induced 
amnesia through exteroceptive behavioral models viz. Elevated plus maze and Y-maze models. Further, whole 
brain acetyl cholinesterase enzyme was estimated through Ellman’s method. Pretreatment with Crataeva nurvala 
ethanolic extract significantly improved spatial learning and memory against scopolamine induced amnesia. 
Moreover, Crataeva nurvala extract decreased rat brain acetyl cholinesterase activity in a dose dependent man-
ner and comparable to the standard drug Piracetam. The results indicate that ethanolic extract of Crataeva nur-
vala might be a useful as nootropic agent to delay the onset and reduce the severity of symptoms associated with 
dementia and Alzheimer’s disease. The underlying mechanism of action of its nootropic potentiality might be at-
tributed to its anticholinesterase property. 
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INTRODUCTION 
Memory function is vulnerable to a va-
riety of pathological condition including 
many neuropsychiatric and neurodegenera-
tive diseases like Alzheimer’s disease 
(Dinesh et al., 2004). Dementia, an age-
related mental problem is a characteristic 
symptom of Alzheimer’s disease (Hanuman-
thachar and Milind, 2006). The cholinergic 
hypothesis claims that decrease in cognitive 
function in dementia is predominantly relat-
ed to a decrease in cholinergic neurotrans-
mission. The cholinergic muscarinic antago-
nist like scopolamine is most widely used 
drug to induce amnesia in experimental ani-
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mals (Kulkarni, 2013). Amnesic mild cogni-
tive impairment (through scopolamine ad-
ministration) represents a transitional state 
between cognitive changes of normal aging 
and the earliest clinical features of Alz-
heimer’s disease (Saxena et al., 2013). Noo-
tropic drugs like Piracetam and cholinester-
ase inhibitors are clinically used to improve 
learning and memory abilities, mood and be-
havior in those neurodegenerative diseases 
(Sibi and Delphia, 2013). But the resulting 
side-effects associated with these synthetic 
drugs have made their utility limited (Hanu-
manthachar and Milind,  2007). Therefore, it 
is worthwhile to explore the utility of tradi-
tional medicines in the treatment of various 
neuropharmacological disorders associated 
with cognitive dysfunction as they are con-
sidered to be safe and economical (Mura-
leedharannair et al., 2011).  
Crataeva nurvala (C. nurvala) Buch-
Ham (Family: Capparidaceae) commonly 
known as Varuna, a well explored traditional 
Indian medicinal plant of Westernghats rou-
tinely used to treat various ailments in par-
ticular urolithiasis and neurological disorders 
(Shiddamallayya et al., 2010, Amod et al., 
2005). It is a medium sized branched decid-
uous plant distributed throughout the river 
banks of southern India and other tropical, 
sub-tropical countries of the world, wild or 
cultivated (Rajesh et al., 2011). It requires 
dry, hot climate and shady places to grow ef-
fectively (Patil et al., 2010). Hence, the pre-
sent study was designed to evaluate the 
nootropic potentiality of C. nurvala through 
several in-vivo neuropharmacological assays 
and biochemical estimations.  
 
MATERIALS AND METHODS 
Collection and authentication of plant  
material 
The stem bark of C. nurvala was collect-
ed from the stream sides of Westernghat, In-
dia and authenticated by Dr. K.V. Naga-
lakshamma, Professor and Head, Department 
of Biotechnology (UG) of St. Aloysius Col-
lege, Mangalore, India. The herbarium 
(voucher specimen no. NGSMIPS/Hb-
04/2011) was preserved in the institutional 
department. 
 
Extraction and fractionation  
500 gm coarsely powdered raw material 
of C. nurvala stem bark was extracted by 
cold maceration with ethanol and concentrat-
ed through rotary flash evaporator at 40 °C 
under reduced pressure and stored in deep 
freezer at -20 °C (Parvin et al., 2011). The 
yield was found to be 17 % w/w. A portion 
of concentrated ethanolic extract was frac-
tionated with different solvents with increas-
ing order of polarity (petroleum ether, chlo-
roform, ethyl acetate, n-butanol and metha-
nol). A flow chat of detailed method of ex-
traction and fractionation is given in Figure 1 
 
Phytochemical analysis 
The crude fractions were subjected to 
different qualitative phytochemical screening 
to identify the presence of various phytocon-
stituents as described by Harborne (Harbone, 
1998). The phytochemicals analyzed were 
alkaloids, phenols, flavonoids, saponins, ter-
penoids, steroids, tannins, carbohydrates, 
proteins and coumarins. 
 
Figure 1: Schematic diagram of extraction and 
fractionation of C. nurvala 
 
 
Screening procedure 
Test for tannins and phenols 
5 ml of fraction was added to 2 ml of 5 % 
of alcoholic FeCl3 solution. Blue-black pre-
cipitate indicated the presence of tannins and 
phenols. 
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Test for alkaloids 
2 ml of 2N HCl was added to 5 ml ex-
tract and heated over water bath for 10 min. 
The cooled solution was filtered and a few 
drops of Dragendorff’s reagent were added. 
Reddish-brown precipitate indicated the 
presence of alkaloid. 
Test for saponins 
About 1 g of dried powdered sample was 
boiled with 10 ml distilled water. Frothing 
persistence indicated the presence of sapo-
nins. 
Test for terpenoids 
5 ml of fraction was mixed with 2 ml of 
chloroform and few drops concentrated 
H2SO4 was carefully added to form a layer. 
Red ring indicated the terpenoids are present. 
Test for steroids 
5 ml of fraction was mixed with 10 ml 
CHCl3 and 1 ml acetic anhydride and few 
drops of concentrated H2SO4 were added. 
Green ring indicated the presence of steroids. 
Test for flavonoids 
To 5 ml of fraction few pieces of magnesium 
ribbon and few drops of concentrated HCl 
were carefully added. Red color indicated the 
presence of flavonoids. 
Test for phlobatannins 
About 2 ml of fraction was boiled with 
2 ml 1 % HCl. Deposition of a red color in-
dicated the presence of phlobatannins. 
Test for amino acids (Ninhydrin test) 
5-6 drops of ninhydrin reagent were added in 
5 ml of fraction and heated over boiling wa-
ter bath for 5 min. Purple coloration indicat-
ed the presence of amino acid. 
Test for proteins (Biuret test) 
5-6 drops of 5 % NaOH and 5-7 drops of 
1 % CuSO4 were added in 2 ml fraction. 
Violet color indicated the presence of pro-
teins. 
 
Drugs and chemicals 
Scopolamine hydrobromide, piracetam, 
sodium carboxy methyl cellulose (Sodium-
CMC), Acetylthiocholine iodide, 5,5′-Dithi-
obis (2-nitrobenzoic acid) (DTNB) were col-
lected from Sigma-Aldrich, Bangalore, In-
dia. All the toxic, standard and test drugs 
(suspended in 0.6 % w/v of sodium CMC so-
lution) were administered in the morning 
session i.e. 9 AM- 10 AM on each day. 
 
Acute toxicity study 
The acute toxicity of ethanolic extract of 
C. nurvala stem bark was evaluated in fe-
male Wistar rats as per OECD guidelines 
425 (Up and Down Procedure). A fixed dos-
age study was adopted for acute toxicity 
study where the limit dose is 2000 mg/kg 
body weight of test animal. Clinical signs of 
toxicity, body weight changes, cage side pa-
rameters and mortality rate were observed 
every hour for the first 6 hours and every day 
for 7 days (Atanu et al., 2013a). 
 
Experimental animals 
Healthy young Wistar rats of either sex 
aged between 8-12 week old and weighing 
between 150-200 g obtained from the institu-
tional animal house were used for in-vivo 
studies. The animals were housed in a room 
under standard environmental condition 
(25 °C and 50-70 % relative humidity) of 
12/12 h light/dark cycle and fed with stand-
ard rat pellet and water ad libitum. Animals 
were allowed to acclimatize for 7 days in la-
boratory conditions prior to experiment 
(Shirish and Shrikant, 2011). The experi-
mental protocol was approved by the Institu-
tional Animal Ethics Committee (IAEC) un-
der the IAEC no.: KSHEMA/AEC/34/2011. 
 
Exteroceptive behavioral model 
Elevated plus maze 
To access the effect of C. nurvala on spa-
tial long term working memory of rats Ele-
vated plus maze test was carried out (Dinesh 
and Varun, 1992). A typical Elevated plus 
maze consists of two open (50x10 cm) and 
two close arms (50x10x40 cm) facing each 
other with a central square (10x10 cm). The 
entire maze has been elevated to a height of 
50 cm from the floor. The animals were 
placed individually at the end of either of 
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open arms facing away from center and the 
time taken by the animals to move from open 
arm to enclose arm was noted on the first 
day (initial transfer latency, ITL). If the ani-
mal did not enter an enclosed arm within 90 
seconds, it was pushed on the back into one 
enclosed arm and the transfer latency was 
given as 90 sec. Later, the animal was al-
lowed to move freely to explore the appa-
ratus for at least 20 sec. After the experi-
ment, the animals were returned to their 
home cages and transfer latency was record-
ed again after 24 hours of the first exposure 
(retention transfer latency, RTL). The trans-
fer latency measured on the first and second 
day trial served as an acquisition (learning) 
and retention (memory) respectively (Kas-
ture et al., 2007). From these, inflexion ra-
tion (IR) was calculated using the formula 
IR = L0 – L1 / L1 
where,  
IR = Inflexion ratio 
L0 = Initial transfer latency in seconds 
L1 = Retention transfer latency in seconds 
A fall in transfer latency on subsequent maze 
exposures was taken as an index of success-
ful retention (Jaiswal and Bhattarcharjee, 
1992). 
 
Y-maze 
The Y-maze task is used to measure spa-
tial working memory through spontaneous 
alteration in behavior in rats. Using food as 
an incentive to reach the goal, animals are ei-
ther required to execute a specific search se-
quence or minimize errors in the quest for 
food. Hence, temporal measurement and er-
ror scoring are the key parameters recorded 
for the evaluation of drug effects adminis-
tered after training (Vasudevan and Milind,  
2009). 
The Y-maze is a three-arm maze made of 
black painted wood with an angle of 120° be-
tween each of the two arms. Each arm is 40 
cm long, 3 cm wide and 13 cm high. The 
three identical arms are randomly designed: 
start arm, in which the animal starts to ex-
plore (A); reward arm, with food stimuli (B) 
and other arm (C).  
Each rat was initially placed at the end of 
arm A, allowed to move freely and the se-
quence and number of arm entries were rec-
orded manually over 8 min period. Rats tend 
to explore the maze systematically, entering 
each arm in turn. The ability to alternate re-
quired that the rats knew which arm they had 
already visited. The percentage of triads in 
which all three arms were represented, i.e., 
ABC, CAB, or BCA but not BAB, was rec-
orded as an ‘alternation’ to estimate short-
term memory. Arms were cleaned with water 
spray between tests to remove odors and res-
idues. The % alternation score for each ani-
mal was defined as the ratio of the actual 
number of alternations to the possible num-
ber (defined as the total number of arm en-
tries minus two) multiplied by 100 as shown 
by the following equation:  
% alternation = [(number of alternations) / 
(total arm entries – 2)] x 100 
The number of arm entries was used as an 
indicator of locomotor activity (Se et al., 
2010). 
 
Experimental protocol 
Sixty healthy Wistar rats of either sex 
were selected randomly and divided into ten 
groups of six animals each to evaluate their 
responses on exteroceptive behavior models. 
The groupings of animals were summarized 
below: 
Group I (Normal control): 
Vehicle (0.6 % w/v sodium CMC) p.o. 
Group II (Negative control): 
Scopolamine (1 mg/kg i.p.) 
Group III (Positive control): 
Piracetam (50 mg/kg) p.o.  
Group IV:  
C. nurvala ethanolic extract (100 mg/kg) 
p.o. 
Group V:  
C. nurvala ethanolic extract (200 mg/kg) 
p.o. 
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Group VI:  
C. nurvala ethanolic extract (400 mg/kg) 
p.o. 
Group VII:  
Piracetam (50 mg/kg) p.o. + Scopola-
mine (1 mg/kg i.p.) 
Group VIII:  
C. nurvala ethanolic extract (100 mg/kg) 
p.o. + Scopolamine (1 mg/kg i.p.) 
Group IX:  
C. nurvala ethanolic extract (200 mg/kg) 
p.o. + Scopolamine (1 mg/kg i.p.) 
Group X:  
C. nurvala ethanolic extract (400 mg/kg) 
p.o. + Scopolamine (1 mg/kg i.p.) 
The dosing for all groups were done for a 
period of 7 days; after 45 minutes of admin-
istration of the last dose on 7th day, amnesia 
was induced by administration of scopola-
mine (1 mg/kg i.p.) to Group II, VII, VIII, IX 
and X respectively. The negative control 
group (Group II) received just one dose of 
scopolamine (1 mg/kg i.p.) on 7th day and 45 
minutes after the administration of scopola-
mine, trials were taken on Elevated plus 
maze and the retention was observed after 24 
hours of the first exposure i.e. on day 8 
(Joshi and Parle, 2006).  
The same experimental protocol was fol-
lowed on the same experimental animals af-
ter one month of rehabilitation for assess-
ment of learning and memory by Y-maze 
model. During experiment, the animals were 
exposed to food and water ad libitum only 
for 1 hour after the maze exposure for the 
day to ensure motivation towards reward ar-
ea (B) (Saxena et al., 2013). 
 
Biochemical estimation  
Collection of brain sample 
Immediately after the experiment ani-
mals were sacrificed by cervical decapitation 
under light anesthesia and whole brain was 
carefully removed from the skull. The fresh 
whole brain was weighed, kept on ice bath, 
rinsed with ice-cold isotonic saline and ho-
mogenized (approximately 20 mg of tis-
sue/ml of phosphate buffer (pH 8.0; 0.1M) in 
a Potter-Elvehjem homogenizer. The ho-
mogenate was centrifuged at 3000 rpm for 
10 min and the resultant cloudy supernatant 
liquid was used for the estimation of AchE 
activity (Vinutha et al., 2007).  
 
Estimation of brain acetyl cholinesterase 
(AChE) activity 
The AchE activity was assessed by 
Ellman’s method (Ellman, 1959). The AchE 
activity is measured by using an artificial 
substrate Acetyl thiocholine (ATC). AchE 
acts on ATC and release thiocholine and ace-
tic acid. Thiocholine further is allowed to re-
act with –SH reagent 5,5-dithio-bis- (2, nitro 
benzoic acid) (DTNB) which is reduced to 
thionitro benzoic acid, a yellow coloured an-
ion with absorption maxima 412 nm. The 
molar extinction coefficient of thionitro ben-
zoic acid is 1.36x10-4/molar/cm. The concen-
tration of thionitro benzoic acid is deter-
mined using Shimadzu UV-1700 Pharmac-
spec UV-Vis spectrophotometer which is di-
rectly proportional to AchE activity. The rate 
of the reaction was calculated using follow-
ing formula  
R = 5.74 x 10-4 x ∆A/CO 
where, 
R = rate in moles of substrate hydrolyzed / 
minute / gm tissue 
∆A = change in absorbance / min  
CO = original concentration of the tissue 
(mg/ml)  
 
Statistical significance 
The results of in-vivo studies were ex-
pressed as mean ± SEM (standard error of 
mean). The difference between the control 
and treated means were analyzed using one 
way analysis of variance (ANOVA). P-
values < 0.05 were taken to be statistically 
significant. Tukey’s test was used for multi-
ple comparisons between all columns. The 
statistical analysis was done using the soft-
ware Graph-pad prism version no: 5.0.  
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RESULTS 
Phytochemical analysis 
Qualitative estimation revealed that stem 
bark extract of C. nurvala were enriched 
with alkaloids, phenolic compounds and tan-
nins, phytosterols and triterpene, flavanoids, 
saponins, and coumarins. The detailed sum-
mary of phytochemical screening of C. nur-
vala fractions is shown below (Table 1). 
 
Acute toxicity study 
No mortality was observed following 
oral administration of C. nurvala ethanolic 
extract even with the highest dose 
(2000 mg/kg). Moreover, no significant 
changes in body weight and behavior were 
observed. Hence, C. nurvala could be safe 
up to the dose of 2000 mg/kg body weight of 
the animal. 
 
Elevated plus maze 
Results suggest pre-treatment with etha-
nolic extract of C. nurvala (100, 200 and 
400 mg/kg body weight) for seven succes-
sive days did not exhibited much difference 
in ITL compared to normal control group but 
in presence of amnesia, higher dose of C. 
nurvala ethanolic extract (400 mg/kg body 
weight) afforded a significant (###p<0.001) 
decrease in TL (score: 35.83 ± 1.537) com-
pared to other lower doses groups (score: 
45.16 ± 1.759 and 38.00 ± 1.693 respective-
ly) and closely approximated to standard 
drug Piracetam (score: 33.16 ± 1.558). How-
ever, all the three doses of extract showed 
improvement spatial learning and memory 
activity in dose dependant manner. Moreo-
ver, in Group VIII, IX and X, significant de-
crease in RTL on Day 8 compared to Day 7 
were observed which elaborate the drugs re-
sponses to overcome the learning and 
memory deficits produced by scopolamine. 
Further, significant improvements in inflex-
ion ratio in the treatment groups suggest its 
nootropic potential (Figure 2). 
 
Y-maze 
Y-maze test was performed to measure 
the effect of C. nurvala extract on spatial 
recognition memory of on Wistar rat model. 
The effect on alteration behavior was studied 
based on two parameters viz. % alteration 
and no. of arm entries. 
 
 
 
 
Table 1: Preliminary phytochemical screening of C. nurvala 
Compounds 
Ethanolic extracts 
Pet. Ether Chloroform Ethyl acetate n-butanol Methanol 
Alkaloids - +++ + ++ - 
Phenols - + + ++ ++ 
Flavanoids - + + + ++ 
Saponins + - - - - 
Phytosterols and 
Triterpene +++ +++ ++ + - 
Tannins - ++ ++ ++ ++ 
Carbohydrates - - + ++ ++ 
Proteins - - - - - 
Carboxylic acid - - - - + 
Coumarins - - - - - 
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One way ANOVA followed by Tukey’s test. Values are mean ± S.E.M., n = 6 in each group. *** p < 0.001 and *p < 0.05 when 
compared to control; ### P < 0.001, and #p < 0.05 when compared to negative control 
Figure 2: Effect of C. nurvala extract on transfer latency (in seconds) on Elevated plus maze 
 
 
Effect on % alteration 
Pre-treatment with ethanolic extract of C. 
nurvala (100, 200 and 400 mg/kg body 
weight) did not exhibit much difference in 
alteration response in comparison to normal 
control group but in presence of amnesia, 
higher dose of C. nurvala ethanolic extract 
(400 mg/kg body weight) afforded signifi-
cant (###p  0.001) alteration response (score: 
50.35 ± 2.364) compared to other lower dos-
es groups (score: 45.98 ± 2.326 and 48.89 ± 
1.185 respectively) and closely approximat-
ed to standard drug Piracetam (score: 55.46 
± 2.062).  However, all the three doses of ex-
tract showed improvement in % alteration in 
dose dependant manner. Moreover, in Group 
VIII, IX and X, significant increase in % al-
teration on Day 8 compared to Day 7 were 
observed (Figure 3). 
Effect on number of arm entries 
Higher dose of C. nurvala ethanolic ex-
tract (400 mg/kg body weight) afforded sig-
nificant (###p  0.001) decline in number of 
arm entries (score: 27.83 ± 0.980) compared 
to other lower doses groups (score: 31.67 ± 
1.085 and 29.50 ± 0.428 respectively) and 
closely approximated to standard drug Pi-
racetam (score: 25.16 ± 1.249).  However, all 
the three doses of extract showed decrease in 
number of arm entries in dose dependant 
manner. Moreover, in Group VIII, IX and X 
significant decrease in number of arm entries 
on Day 8 compared to Day 7 were observed 
(Figure 4). 
 
Estimation of whole brain acetylcholine es-
terase (AchE) activity 
The acetylcholiesterase activity of whole 
brain was significantly (***p < 0.001) eleva-
ted after scopolamine (1 mg/kg, i.p.) treat-
ment. Pre-treatment with Piracetam (50 mg/ 
kg, p.o.) and C. nurvala (100, 200 and 
400 mg/kg, p.o.) significantly (###p < 0.001) 
lowered AChE activity (Figure 5). 
 
DISCUSSION 
Cognition is a process of storing se-
quence of information in a systematic man-
ner by which one become aware of their sur-
roundings, objects and thoughts (Ashutosh et 
al., 2002). Cognitive impairment is one of 
the major health problems in normal aged 
life as well as in some neurological disease 
conditions like Alzheimer’s (Vasudevan and 
Milind, 2007). Herbal cognition enhancers 
can be used as an alternative to facilitate at-
tention abilities and to attenuate the impair-
ment of cognitive functions associated with 
age and age-related pathologies (Oguz et al., 
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2011). Since, no study had been conducted 
to evaluate the nootropic potential of stem 
bark of C. nurvala, the present study was 
conducted. 
The phytochemical screening revealed 
stem bark fractions of C. nurvala were en-
riched with different secondary metabolites 
in their respective fractions. Further, various 
bioactive phytoconstituents viz. β-sitosterol, 
stigmasterol, melatonin, lupeol, catechin had 
been isolated from the stem bark of C. nur-
vala extract (Atanu et al., 2013b, 2014). 
Melatonin is a potent anticholinesterase and 
antioxidant agent which might be associated 
with the nootropic activity of C. nurvala ex-
tract (Jian-zhi and Ze-fen, 2006; Jemima et 
al., 2011).  
 
 
One way ANOVA followed by Tukey’s test. Values are mean ± S.E.M., n = 6 in each group. *** p < 0.001 and *p < 0.05 when 
compared to control; ### P < 0.001, and #p < 0.05 when compared to negative control. 
Figure 3: Effect of C. nurvala extract on % Alteration behavior in Y-maze 
 
 
 
One way ANOVA followed by Tukey’s test. Values are mean ± S.E.M., n = 6 in each group. *** p < 0.001 and *p < 0.05 when 
compared to control; ### P < 0.001, and #p < 0.05 when compared to negative control. 
Figure 4: Effect of C. nurvala on number of arm entries in Y-maze 
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One way ANOVA followed by Tukey’s test. Values are mean ± S.E.M., n = 6 in each group. *** p < 0.001 and *p < 0.05 when 
compared to control; ### P < 0.001, and #p < 0.05 when compared to negative control. 
Figure 5: Effect of C. nurvala extract on whole brain acetyl cholinesterase enzyme 
 
 
The findings from Elevated plus maze 
test suggest C. nurvala ethanolic extract 
showed protective effect in transfer latency 
against scopolamine induced amnesia in 
dose dependent manner. Moreover, the de-
crease in transfer latency during retention pe-
riod suggested the drug response to over-
come learning and memory deficit produced 
by scopolamine. Further, nootropic activity 
was evaluated through Y-maze test and re-
sults suggest an improvement in % alteration 
and decrease in number of arm entries 
against scopolamine induced amnesia in 
dose dependent manner. These provide an 
adequate scientific promise to validate the 
nootropic potency of C. nurvala extract.   
Moreover, C. nurvala extract significant-
ly inhibit whole brain AchE against scopol-
amine induced amnesia in dose dependent 
manner and thereby could increase the avail-
ability of acetylcholine in brain and in cho-
linergic synapse. These observations postu-
lated potent anticholinesterase activity of C. 
nurvala extract which might be one of the 
possible mechanisms to encounter with cog-
nitive disorders. 
Therefore, in the present study we observed 
that C. nurvala extract  
(i) showed improvement in memory of Wistar 
rats when tested on exteroceptive behavioral 
model viz. elevated plus maze and Y-maze  
(ii) inhibited whole brain acetylcholinesterase 
enzyme activity. Thus, a combination of an-
ticholinesterase and neuroprotective effects 
exhibited by C. nurvala extract may be re-
sponsible for its nootropic potentiality. 
However, investigations using more ex-
perimental paradigms particularly with 
isolated bioactive compounds like mela-
tonin may be required for further con-
firmation of nootropic potential of C. 
nurvala stem bark in the treatment of Alz-
heimer’s and other cognitive disorders.  
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